Clinical Trial Update: A Pilot Study Comparing the Use of Low-target Versus Conventional Target Advagraf [NA]

View source ↗

Summary

A pilot randomized trial comparing low-target versus conventional target dosing of Advagraf (tacrolimus extended-release) in transplant patients with diabetes t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Graft Rejection

Drugs mentioned

• Advagraf (tacrolimus)

Snippet

Sponsor: University of British Columbia | Conditions: Acute Graft Rejection, Diabetes | NA | Status: COMPLETED | Results posted: 2020-02-11